温氏股份(300498.SZ):2022年公司白羽肉雞銷量約1800萬隻,2023年銷售目標約3000萬隻
格隆匯5月29日丨温氏股份(300498.SZ)近期組織多場路演活動,問答環節中,就“公司是否有養殖白羽肉雞品種,規模大概有多大?”,公司回覆稱,近幾年,公司開始佈局白羽肉雞行業,建立有專業的白羽雞育種公司,目前仍處於積極探索和佈局過程中。2022年公司白羽肉雞銷量約1800萬隻。2023年白羽肉雞銷售目標約3000萬隻。與公司黃羽肉雞主營業務體量相比,白羽肉雞目前體量較小,但增速較快。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.